These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24448760)

  • 21. Three-dimensional cell cultures in toxicology.
    Pampaloni F; Stelzer E
    Biotechnol Genet Eng Rev; 2010; 26():117-38. PubMed ID: 21415878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism: a bottleneck in in vitro toxicological test development. The report and recommendations of ECVAM workshop 54.
    Coecke S; Ahr H; Blaauboer BJ; Bremer S; Casati S; Castell J; Combes R; Corvi R; Crespi CL; Cunningham ML; Elaut G; Eletti B; Freidig A; Gennari A; Ghersi-Egea JF; Guillouzo A; Hartung T; Hoet P; Ingelman-Sundberg M; Munn S; Janssens W; Ladstetter B; Leahy D; Long A; Meneguz A; Monshouwer M; Morath S; Nagelkerke F; Pelkonen O; Ponti J; Prieto P; Richert L; Sabbioni E; Schaack B; Steiling W; Testai E; Vericat JA; Worth A
    Altern Lab Anim; 2006 Feb; 34(1):49-84. PubMed ID: 16522150
    [No Abstract]   [Full Text] [Related]  

  • 23. SEURAT: Safety Evaluation Ultimately Replacing Animal Testing--recommendations for future research in the field of predictive toxicology.
    Daston G; Knight DJ; Schwarz M; Gocht T; Thomas RS; Mahony C; Whelan M
    Arch Toxicol; 2015 Jan; 89(1):15-23. PubMed ID: 25433540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Food for thought ... why no new in vitro tests will be done for REACH by registrants.
    Rovida C
    ALTEX; 2010; 27(3):175-83. PubMed ID: 21113560
    [No Abstract]   [Full Text] [Related]  

  • 25. Two Good Read-across Practice workshops. Making it work for you!
    Maertens A; Hubesch B; Rovida C
    ALTEX; 2016; 33(3):324-6. PubMed ID: 27410255
    [No Abstract]   [Full Text] [Related]  

  • 26. Commentary on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Prueitt RL; Beck BD
    Hum Exp Toxicol; 2010 Jan; 29(1):7-9. PubMed ID: 20061461
    [No Abstract]   [Full Text] [Related]  

  • 27. An integrated summary of commentary on the National Academy of Sciences report on ''Toxicity testing in the 21st century: a vision and a strategy''.
    Gibson JE
    Hum Exp Toxicol; 2010 Jan; 29(1):33-5. PubMed ID: 20061466
    [No Abstract]   [Full Text] [Related]  

  • 28. Using toxicological evidence from QSAR models in practice.
    Benfenati E; Pardoe S; Martin T; Gonella Diaza R; Lombardo A; Manganaro A; Gissi A
    ALTEX; 2013; 30(1):19-40. PubMed ID: 23338804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards tailored assays for cell-based approaches to toxicity testing.
    Rossini GP; Hartung T
    ALTEX; 2012; 29(4):359-72. PubMed ID: 23138507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
    Kroeger M
    Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Call to curb lab tests on dogs.
    Turner M
    Nature; 2011 Jun; 474(7353):551. PubMed ID: 21720337
    [No Abstract]   [Full Text] [Related]  

  • 32. International STakeholder NETwork (ISTNET) for creating a developmental neurotoxicity testing (DNT) roadmap for regulatory purposes.
    Crofton K; Fritsche E; Ylikomi T; Bal-Price A
    ALTEX; 2014; 31(2):223-4. PubMed ID: 24794006
    [No Abstract]   [Full Text] [Related]  

  • 33. A review of the status of alternative approaches to animal testing and the development of integrated testing strategies for assessing the toxicity of chemicals under REACH--a summary of a DEFRA-funded project conducted by Liverpool John Moores University and FRAME.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod J
    Altern Lab Anim; 2006 Mar; 34 Suppl 1():149-58. PubMed ID: 16555968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans.
    Blaauboer BJ; Boekelheide K; Clewell HJ; Daneshian M; Dingemans MM; Goldberg AM; Heneweer M; Jaworska J; Kramer NI; Leist M; Seibert H; Testai E; Vandebriel RJ; Yager JD; Zurlo J
    ALTEX; 2012; 29(4):411-25. PubMed ID: 23138511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies to replace in vivo acute systemic toxicity testing. The report and recommendations of ECVAM Workshop 50.
    Gennari A; van den Berghe C; Casati S; Castell J; Clemedson C; Coecke S; Colombo A; Curren R; Dal Negro G; Goldberg A; Gosmore C; Hartung T; Langezaal I; Lessigiarska I; Maas W; Mangelsdorf I; Parchment R; Prieto P; Sintes JR; Ryan M; Schmuck G; Stitzel K; Stokes W; Vericat JA; Gribaldo L;
    Altern Lab Anim; 2004 Oct; 32(4):437-59. PubMed ID: 15651930
    [No Abstract]   [Full Text] [Related]  

  • 36. Formation of mechanistic categories and local models to facilitate the prediction of toxicity.
    Cronin MT; Enoch SJ; Hewitt M; Madden JC
    ALTEX; 2011; 28(1):45-9. PubMed ID: 21311849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the replacement strategy, as it exists today in the EU for cosmetics, the way forward ?
    Rogiers V
    Arch Toxicol; 2011 May; 85(5):363-4. PubMed ID: 21528384
    [No Abstract]   [Full Text] [Related]  

  • 38. Integrated testing strategies for use with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():7-27. PubMed ID: 19025329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advancing alternatives analysis: The role of predictive toxicology in selecting safer chemical products and processes.
    Malloy T; Zaunbrecher V; Beryt E; Judson R; Tice R; Allard P; Blake A; Cote I; Godwin H; Heine L; Kerzic P; Kostal J; Marchant G; McPartland J; Moran K; Nel A; Ogunseitan O; Rossi M; Thayer K; Tickner J; Whittaker M; Zarker K
    Integr Environ Assess Manag; 2017 Sep; 13(5):915-925. PubMed ID: 28247928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alternative methods to animal experiments. What can they afford in the safety testing of chemical substances under REACH?].
    Lilienblum W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1434-43. PubMed ID: 19137219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.